INDEMNIFICATION AGREEMENTIndemnification Agreement • March 8th, 2017 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionTHIS AGREEMENT (the “Agreement”) is made and entered into as of __________, ___ between Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and _______________, a director, officer or member of the executive committee of the Company (“Indemnitee”).
TERMINATION AGREEMENTTermination Agreement • March 8th, 2017 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 8th, 2017 Company Industry JurisdictionThis Termination Agreement (this “Termination Agreement”) entered into as of December 8, 2016, effective as of June 1, 2015 (the “Termination Date”), is by and between CATALYST BIOSCIENCES, INC., a corporation organized under the laws of the state of Delaware, United States of America, with a place of business at 260 Littlefield Avenue, South San Francisco, California 94080 (“CATALYST”) and WYETH LLC, a wholly-owned subsidiary of PFIZER INC., a corporation organized under the laws of the State of Delaware, United States of America, with a place of business at 235 East 42nd Street, New York, New York, 10017 (“WYETH”). Each of CATALYST and WYETH hereinafter referred to individually as a “Party” and together as the “Parties.”